Albus M, Zahn T P, Breier A
Mental State Hospital, Haar, Federal Republic of Germany.
Eur Arch Psychiatry Clin Neurosci. 1992;241(6):337-44. doi: 10.1007/BF02191958.
The anxiogenic effects of yohimbine, a specific alpha-2-receptor antagonist were examined by administering 20 mg yohimbine orally to 8 panic patients on placebo treatment, 7 panic patients on alprazolam treatment and 12 controls using a double-blind randomized design, instructions that minimized the expectancy of experiencing a panic attack and two additional structured situations. Yohimbine induced more pronounced increases in anxiety and panicky ratings, norepinephrine secretion, maximum heart rate and high heart rate variability and decreases in skin temperature in panic patients compared with controls. However, possibly owing to an instructional set and experimental design that distracted patients from unpleasant bodily sensations no panic attacks were observed.
通过双盲随机设计,对8名接受安慰剂治疗的惊恐症患者、7名接受阿普唑仑治疗的惊恐症患者和12名对照者口服20毫克育亨宾,研究了一种特定的α-2受体拮抗剂育亨宾的致焦虑作用。研究采用了能将惊恐发作预期降至最低的指导语以及另外两种结构化情境。与对照组相比,育亨宾使惊恐症患者的焦虑和恐慌评分、去甲肾上腺素分泌、最大心率和高心率变异性显著增加,皮肤温度降低。然而,可能由于指导语设置和实验设计分散了患者对不愉快身体感觉的注意力,未观察到惊恐发作。